Olfactory glia and CNS repair: a step in the road from proof of principle to clinical application
Considerable advances have been made in the last decade that in vitro expansion has not led to loss of function or uncontrolled cell proliferation. This study thus represents in devising and evaluating cell transplantation strategies a significant advance for those considering olfactory glia for enhancing axon regeneration for patients with spinal as a potential cell type to use in clinical trials aimed cord trauma, and in achieving remyelination in chronic at enhancing regeneration of axons following spinal demyelinating diseases such as multiple sclerosis. Thus, a cord trauma. number of studies have established that transplantation of This paper also highlights another important point for glial cells can have beneficial consequences in experimental those trying to make the transition from a proof of models of spinal cord trauma and demyelination. In principle established using rodents to the use of the particular, in rats, it has been shown that implantation of approach in man, because it demonstrates once again that Schwann cells or olfactory glial cells results in significant the cultivation and expansion of human cells is not as regeneration of axons across spinal cord transection sites straightforward as expansion of their rodent counterparts. and that this is associated with an improvement of Thus, while rodent olfactory glia can be selected through locomotor function (Cheng et al., 1997; Xu et al., their expression of antigens recognized by the O4 1999; Ramón-Cueto et al., 2000) . A potential therapeutic monoclonal antibody, human cells do not express this superiority of olfactory glia over Schwann cells was antigen. Instead, use had to be made of another marker demonstrated by experiments in which the number of for this cell type, the low affinity NGFr. However, in regenerating axons crossing a transection site was contrast to rodent cells this receptor is downregulated dramatically increased when olfactory glia were placed at during culture, making identification, and thus further the interface between a Schwann-cell-filled guidance tube selection of olfactory glia difficult, should this be required and the damaged spinal cord (Ramón-Cueto et al., 1998) .
prior to therapeutic use. Such observations indicate that The reports of such experiments stimulate considerable new reagents and techniques have to be developed by media interest and, not unexpectedly, raise patient hopes those who need to work with human cells. This imposes for a cure to their disability. There is therefore a major considerable difficulties for the researcher, since obtaining challenge for neuroscientists and clinicians to build on the regular supplies of human cells required to test and proof of the principle established by these experimental evaluate culture methods and reagents is less straightforward studies with a view to adapting the approach for clinical use.
than is the case with rodent tissue, making progress slow. In any situation where cell therapy is being considered, A further constraint to making the rodent-human transition a number of practical issues have to be addressed before is that the development work required is often perceived any clinical trial can be contemplated. One of the most as unattractive scientifically because progress is slow. fundamental of these issues is whether the required cells Moreover, the work is also often perceived as lacking the can be obtained from the patient themselves, since this novelty so essential if work is to be published in highwould avoid the necessity for immunosuppression. With ranking journals, a prerequisite for survival in these Schwann cells this issue has largely been resolved. It is competitive days. Therefore, it is important that journals possible to expand human Schwann cells from small such as Brain take a special interest in the studies that amounts of starting material, using a combination of are required to take proof of principle established in heregulin and forskolin, and to drive cell multiplication to
